Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.7 USD | +2.91% | +5.01% | +20.62% |
03:21pm | The specter of stagflation rears its ugly head again | |
02:53pm | Merck Lifts Full-Year 2024 Outlook Following First-Quarter Beat | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.62% | 322B | |
+23.88% | 562B | |
-6.10% | 358B | |
+8.49% | 297B | |
+13.40% | 219B | |
+6.29% | 199B | |
-10.22% | 196B | |
-9.55% | 149B | |
-5.70% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co. Says Molnupiravir Cuts Risk of Severe COVID-19 Based on Trial Data